Market research to gain the competitive edge
The History of High Throughput Screening
for Drug Discovery: 1998-2005
Overview Analysis of How HTS Practices Have Changed
  1. Analysis of the HTS market size and growth from 1998–2005
  2. Analysis by segment and product category
  3. Analysis of trends in areas such as cell-based and biochemical assays, target validation, secondary screening, in vitro ADME/Tox, high content screening, compounds and targets, label-free technologies, miniaturization, budgets and spending, the changing competitive environment and future goals.
The Ph.D. and MBA analysts provide an in-depth analysis of the HTS market.
   Report Overview
This 200-page report, an essential tool for understanding how HTS has changed and where it is headed is based on in-depth analysis and write-ups of 318 interviews with HTS laboratory directors and 238 interviews with worldwide suppliers of products and services from 1998–2005.
   Order Form
Report Ist Copy Price Additional Copies Total

The History of High Throughput Screening for Drug Discovery: 1998-2005

US $1,500
  @ $150 ea.   
CD-ROM/Site License (Only Available with Purchase of Full Report)

US $550
    @ $300 ea.    
Shipping and Handling:
USA US $30.00

  Intl.   US $65.00
California add 9.25% sales tax
Total Payment Enclosed  
    Shipping Informaton
  Name:         Title:         
  Company:    Phone:      
  Street:        City:          
  State/Country       Zip/Code:   
    Method of Payment
  Checks or Money Orders in US Dollars from a US Bank, or credit card payments are accepted.
  Check Make payable to HighTech Business Decisions    Visa      MasterCard     AMEX     
 Credit Card #
 Exp. Date       
 Card Holder Name
    Fax or E-Mail Order Form to HighTech Business Decisions